New study below.
I reviewed the literature a year ago in:
"Foods/Supplements-Vitamins: Vitamin K"
In the new study:
"Vitamin K2, a menaquinone ... targets castration-resistant prostate cancer cell-line by activating apoptosis signaling."
-Patrick
ncbi.nlm.nih.gov/pubmed/294...
Food Chem Toxicol. 2018 Feb 9. pii: S0278-6915(18)30083-8. doi: 10.1016/j.fct.2018.02.018. [Epub ahead of print]
Vitamin K2, a menaquinone present in dairy products targets castration-resistant prostate cancer cell-line by activating apoptosis signaling.
Dasari S1, Samy ALPA1, Kajdacsy-Balla A2, Bosland MC2, Munirathinam G3.
Author information
1
Department of Biomedical Sciences, University of Illinois-College of Medicine, Rockford, IL, USA.
2
Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
3
Department of Biomedical Sciences, University of Illinois-College of Medicine, Rockford, IL, USA. Electronic address: mgnanas@uic.edu.
Abstract
The aim of this study was to evaluate the therapeutic effects of vitamin K2 (VK2) on castration-resistant prostate cancer (CRPC) and its anti-cancer mechanisms in a pre-clinical study using a VCaP cell line (ATCC® CRL-2876™) which was established from a vertebral bone metastasis from a patient with hormone refractory prostate cancer. Our data showed that VK2 significantly inhibited CRPC VCaP cell proliferation in a dosedependent manner at 48 h treatment in vitro. In addition, VK2 reduced the migration potential of VCaP cells and inhibited anchorage-independent growth of these cells. Our results also showed that VK2 induces apoptosis in VCaP cells. Furthermore, VK2 enforced growth arrest in VCaP cells by activating cellular senescence. Notably, VK2 treatment elevated the levels of reactive oxygen species in VCaP cells. Western blot analysis revealed that VK2 downregulated the expression of androgen receptor, BiP, survivin, while activating caspase-3 and -7, PARP-1, p21 and DNA damage response marker, phospho-H2AX, in VCaP cells. In conclusion, our study suggests that VK2 might be a potential anti-cancer agent for CRPC by specifically targeting key anti-apoptotic, cell cycle progression and metastasis-promoting signaling molecules.
KEYWORDS:
Apoptosis; Prostate cancer; Reactive oxygen species and DNA damage; Vitamin K2
PMID: 29432837 DOI: 10.1016/j.fct.2018.02.018